Researchers have examined cellular crosstalk between the gut and liver during sepsis, helping us better understand sepsis ...
A new drug developed by Australian researchers has shown promising results in reducing sepsis in a Phase II clinical trial involving 180 patients. The carbohydrate-based treatment works by calming a ...
Add Yahoo as a preferred source to see more of our stories on Google. Signs of sepsis Sepsis is a life-threatening condition in which the body overreacts to an infection and starts attacking its own ...
CCO Hoda Asmar says the health system improved sepsis care during the first two years by focusing on two processes, including early administration of antibiotics. After committing to improve sepsis ...
Sepsis is the body’s extreme reaction to an infection, according to the Centers for Disease Control and Prevention (CDC). Bacterial infections are the most common cause of sepsis, according to the CDC ...
Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are ...
Sepsis is an underestimated killer. Nearly a quarter of patients treated for sepsis in hospital will die, but because so many different illnesses can predispose patients to experiencing it, it’s ...
Since Froedtert Hospital adopted the test, the mortality rate for sepsis patients has decreased by 42% and hospital length of stay has been reduced by nearly two days for patients with a suspected ...
According to the Centers for Disease Control and Prevention, there are more than 1.7 million cases of sepsis every year, leading to 300,000 annual deaths. "Sepsis is a potentially lethal condition; ...
A new experimental treatment has shown encouraging results in a recent clinical trial, offering new hope against one of medicine’s most challenging conditions.
Chicago-based sepsis diagnosing biotech Prenosis announced two $20 million milestones this morning, Series A financing and a large government contract.
Ciaran and Orlaith Staunton have reached a historic milestone in their decade-long campaign to reform American healthcare.